Cengild Medical

Equities

CENGILD

MYQ0243OO004

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.31 ^MYR	+1.64%		+1.64%	-7.46%

Apr. 22	Cengild Medical Berhad Announces Resignation of Mr. Micheal Bong Enn Chung @ Micheal Wong Enn Chung as the Group Chief Executive Officer	CI
Apr. 22	Cengild Medical Berhad Appoints Miss Yap Soh Kim as the Acting Chief Executive Officer	CI

Cengild Declares Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 29 March 2024

February 27, 2024 at 08:08 am EST

The Board of Directors of Cengild announced that the Company has declared a single tier interim dividend of 0.37 sen per ordinary share in respect of the financial year ending 30 June 2024. The single tier interim dividend will be paid on 29 March 2024 to the shareholders whose names appear in the Record of Depositors on 13 March 2024.

Latest news about Cengild Medical

Cengild Medical Berhad Announces Resignation of Mr. Micheal Bong Enn Chung @ Micheal Wong Enn Chung as the Group Chief Executive Officer	Apr. 22	CI
Cengild Medical Berhad Appoints Miss Yap Soh Kim as the Acting Chief Executive Officer	Apr. 22	CI
126,330,000 Ordinary Shares of Cengild Medical Berhad are subject to a Lock-Up Agreement Ending on 18-APR-2024.	Apr. 17	CI
Cengild Declares Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 29 March 2024	Feb. 27	CI
Cengild Medical Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 27	CI
Cengild Medical Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 24	CI
Cengild Medical Berhad Announces Retirement of Yap Soh Kim as Chief Executive Officer	23-10-31	CI
Cengild Medical Berhad Announces Resignation of Yeng Shi Mei as Company Secretary	23-09-29	CI
Cengild Medical Berhad Announces Appointment of Wong Siew Yeen as Company Secretary	23-09-29	CI
Cengild Medical Berhad Announces Appointment of Tee Thiam Chai as Company Secretary	23-09-29	CI
Cengild Medical Berhad Announces Resignation of Chong Lay Kim as Company Secretary	23-09-29	CI
Cengild Medical Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-08-24	CI
Cengild Medical Berhad Declares Single Tier Interim Dividend in Respect of the Financial Year Ended 30 June 2023, Will Be Paid on 25 September 2023	23-08-22	CI
Cengild Medical Form JV to Launch Oncology Centers	23-08-01	MT
Cengild Medical Completes Special Issue to Bumiputera Investors	23-07-18	MT
Cengild Medical Berhad Appoints MICHEAL BONG ENN CHUNG @ MICHEAL WONG ENN CHUNG as Chief Executive Officer, Effective 01 July 2023	23-06-30	CI
Cengild Medical Berhad Announces Re-designation of Yap Soh Kim as Chief Executive Officer of Cengild Sdn Bhd, Effective 1 July 2023	23-06-30	CI
Cengild Medical Berhad Announces Demise of Goh Khean Lee, Executive Director	23-06-06	CI
Cengild Medical Prices Placement Shares	23-06-02	MT
Cengild Medical Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-30	CI
126,330,000 Ordinary Shares of Cengild Medical Berhad are subject to a Lock-Up Agreement Ending on 18-APR-2023.	23-04-17	CI
Cengild Medical Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 June 2023, Payable on 29 March 2023	23-02-28	CI
Cengild Medical Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-28	CI
Cengild Medical Berhad Announces the Re-Designation of Mr. Kua Choo Kai from Chairman of Remuneration Committee to Member of Remuneration Committee	23-02-28	CI
Cengild Medical Berhad Announces the Re-Designation of Dr. Chong Su-Lin from Member of Remuneration Committee to Chairman of Remuneration Committee	23-02-28	CI

Chart Cengild Medical

Duration

Period

More charts

Company Profile

Cengild Medical Berhad is a Malaysia-based investment holding company. The Company, through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. The Company has around 36,588 sq. ft. medical center, which provides diagnostic and therapeutic facilities with 28 licensed beds, two fully equipped operating theatres, three endoscopy suites, and imaging facilities such as fibro scan, ultrasonography, computerized tomography (CT) scan, fluoroscopy, angiography equipment for endoscopic retrograde cholangiopancreatography (ERCP)s and other procedures. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy, and histopathology services. Its subsidiaries include Cengild Sdn. Bhd., and Galen Primer Sdn. Bhd.

Sector

Healthcare Facilities & Services

Calendar

2024-05-27 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
CENGILD MEDICAL	-7.46%	54.15M
AIER EYE HOSPITAL GROUP CO., LTD.	-20.16%	16.21B
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.44B
IHH HEALTHCARE	+3.98%	11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.72%	10.79B
ENCOMPASS HEALTH CORPORATION	+23.61%	8.26B
RAMSAY HEALTH CARE LIMITED	-2.19%	7.68B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.2B
THE ENSIGN GROUP, INC.	+4.49%	6.67B
GLOBAL HEALTH LIMITED	+50.89%	4.66B

Hospitals, Clinics & Primary Care Services